Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NFAT5 transcription factor (tonicity-responsive enhancer binding protein, TonEBP) (NFAT5 (TonEBP))
- Target
- NFAT5 (TonEBP)
- Molecular classification
- Transcription factor
01
Overview
NFAT5 (TonEBP) is a transcription factor in the Rel/NFAT family that is activated by hypertonic stress in mammalian cells. Upon activation, it binds to tonicity-responsive enhancer (TonE) elements in the promoters of target genes, leading to increased transcription of genes that encode proteins involved in the synthesis and transport of organic osmolytes such as betaine, inositol, and taurine, as well as heat-shock proteins. This allows cells to adapt to and survive hyperosmotic environments by restoring cell volume and minimizing stress-induced apoptosis[1]. Osmoprotection through this pathway is essential in tissues that are regularly exposed to osmotic fluctuations, such as the kidney medulla.
- Other names
- tonicity-responsive enhancer binding proteinTonEBPnuclear factor of activated T cells 5
02
Mechanism of action
Drugs or genetic interventions that increase or decrease NFAT5 activity alter the expression of osmoprotective genes, influencing cellular resistance to osmotic stress[1]
03
Biological functions
OsmoregulationRegulation of osmoprotective gene expressionCell volume regulationResponse to hypertonic stress
04
Disease associations
Kidney diseaseInflammationOther conditions involving osmotic imbalance
05
Safety considerations
possible systemic effects due to altered cell volume regulation and electrolyte balance if pathway is pharmacologically disrupted[1]
06
Biomarkers
expression level of NFAT5osmoprotective gene products (e.g., aldose reductase, betaine transporter BGT1, sodium-myo-inositol transporter SMIT)
Beyond the preview
Go deeper on NFAT5 transcription factor (tonicity-responsive enhancer binding protein, TonEBP) (NFAT5 (TonEBP)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NFAT5 transcription factor (tonicity-responsive enhancer binding protein, TonEBP) (NFAT5 (TonEBP)).